CN Stock MarketDetailed Quotes

603590 Beijing Konruns Pharmaceutical

Watchlist
  • 23.40
  • -1.01-4.14%
Market Closed Oct 11 15:00 CST
3.74BMarket Cap27.37P/E (TTM)

Beijing Konruns Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-10.16%405.02M
20.67%199.24M
6.15%920.01M
22.46%720.04M
21.33%450.84M
5.71%165.11M
7.03%866.73M
-1.44%587.99M
-18.43%371.59M
-25.99%156.19M
Operating revenue
-10.16%405.02M
20.67%199.24M
6.15%920.01M
22.46%720.04M
21.33%450.84M
5.71%165.11M
7.03%866.73M
-1.44%587.99M
-18.43%371.59M
-25.99%156.19M
Other operating revenue
-73.94%491.76K
----
-85.60%2.26M
----
-88.02%1.89M
----
-86.57%15.68M
----
-81.65%15.76M
----
Total operating cost
-8.70%317.15M
11.98%150.67M
6.36%773.68M
8.37%548.85M
9.21%347.35M
5.51%134.55M
8.14%727.45M
9.78%506.47M
-11.94%318.06M
-10.42%127.53M
Operating cost
-10.74%42.39M
27.67%22.46M
-19.90%101.05M
-14.33%73.22M
-12.44%47.49M
-17.26%17.59M
19.29%126.16M
9.24%85.48M
-1.26%54.23M
23.15%21.26M
Operating tax surcharges
14.00%3.46M
-4.88%1.33M
-9.19%5.9M
-7.54%4.64M
-15.34%3.03M
-12.96%1.4M
-25.24%6.5M
-26.06%5.01M
-31.37%3.58M
-46.11%1.61M
Operating expense
-11.75%193.75M
19.72%90.45M
11.68%472.59M
13.51%344.49M
17.42%219.53M
5.61%75.55M
8.14%423.15M
14.95%303.49M
-13.59%186.97M
-23.34%71.54M
Administration expense
22.07%56.52M
26.78%26.16M
7.76%110.7M
-4.86%70.32M
-3.12%46.3M
-0.16%20.64M
16.66%102.72M
15.93%73.91M
11.83%47.79M
15.12%20.67M
Financial expense
75.66%-2.26M
43.70%-1.05M
35.84%-11.46M
31.54%-11.03M
8.53%-9.29M
56.33%-1.87M
23.65%-17.86M
10.01%-16.12M
16.55%-10.15M
18.22%-4.28M
-Interest expense (Financial expense)
328.56%2.64M
314.84%1.23M
221.89%2.78M
117.45%1.23M
55.42%615.48K
42.45%297.32K
-38.66%864.06K
-46.15%565.22K
-50.95%396.02K
-41.71%208.73K
-Interest Income (Financial expense)
7.47%-6.36M
9.92%-2.92M
25.63%-13.77M
31.38%-10.02M
29.82%-6.87M
28.90%-3.24M
24.65%-18.52M
22.75%-14.59M
22.72%-9.79M
24.83%-4.56M
Research and development
-42.18%23.29M
-46.72%11.32M
9.38%94.91M
22.87%67.22M
13.01%40.29M
26.98%21.24M
-15.15%86.78M
-17.66%54.71M
-34.08%35.65M
4.11%16.73M
Credit Impairment Loss
-124.61%-180.06K
-100.30%-4.22K
-232.40%-7.25M
-317.39%-2.09M
-117.11%-80.17K
-31.28%1.39M
-578.90%-2.18M
161.26%960.72K
127.83%468.43K
154.59%2.02M
Asset Impairment Loss
----
----
-161.49%-11.91M
----
----
----
---4.56M
----
----
----
Other net revenue
-23.90%13.05M
-67.86%1.7M
-313.40%-3.04M
-59.93%17.34M
-60.60%17.15M
-79.49%5.28M
-97.41%1.43M
87.07%43.26M
141.92%43.54M
480.22%25.74M
Fair value change income
153.15%923.48K
100.59%1.05M
86.81%-866.8K
-1,337.16%-1.64M
---1.74M
-20.09%522.45K
-115.76%-6.57M
--132.62K
----
-59.47%653.82K
Invest income
-0.53%10.11M
-138.89%-536.93K
616.30%5.56M
-61.86%10.78M
-65.16%10.16M
-93.57%1.38M
82.17%-1.08M
326.71%28.27M
315.12%29.18M
11,104.37%21.49M
-Including: Investment income associates
-20.72%-1.22M
-91.44%-657.01K
7.20%-8.79M
-109.38%-1.9M
-104.77%-1.01M
-101.60%-343.2K
-225.96%-9.47M
1,502.43%20.22M
2,132.89%21.12M
11,087.81%21.46M
Asset deal income
----
----
---8.23K
----
----
----
----
----
----
----
Other revenue
-75.01%2.2M
-40.15%1.19M
-27.69%11.43M
-26.02%10.28M
-36.61%8.81M
25.91%1.99M
-17.07%15.81M
-23.09%13.9M
9.82%13.9M
-29.07%1.58M
Operating profit
-16.33%100.93M
40.27%50.26M
1.83%143.28M
51.09%188.53M
24.28%120.64M
-34.14%35.83M
-26.83%140.7M
-21.22%124.78M
-13.63%97.07M
-25.60%54.41M
Add:Non operating Income
-98.29%978.72
-99.11%444.93
-48.38%261.5K
-49.07%257.56K
1,201.68%57.38K
2,292.92%50.19K
-87.64%506.62K
9,282.50%505.72K
203.60%4.41K
188.88%2.1K
Less:Non operating expense
-83.91%129.65K
-100.00%26.66
2,229.06%20.81M
58.03%1.01M
238.14%805.78K
1,194.09%802.24K
-88.14%893.56K
19.52%638.3K
1,705.46%238.3K
404.73%61.99K
Total profit
-15.92%100.8M
43.28%50.26M
-12.53%122.73M
50.64%187.77M
23.81%119.89M
-35.45%35.08M
-25.70%140.32M
-21.04%124.65M
-13.82%96.83M
-25.67%54.35M
Less:Income tax cost
-18.12%13.52M
-34.48%3.42M
-494.83%-64.84M
146.32%24.94M
135.22%16.52M
33.49%5.22M
-23.32%16.42M
-35.07%10.12M
-43.12%7.02M
-55.19%3.91M
Net profit
-15.57%87.28M
56.86%46.85M
51.40%187.57M
42.19%162.84M
15.10%103.37M
-40.79%29.86M
-26.01%123.89M
-19.50%114.52M
-10.21%89.81M
-21.67%50.44M
Net profit from continuing operation
-15.57%87.28M
56.86%46.85M
51.40%187.57M
42.19%162.84M
15.10%103.37M
-40.79%29.86M
-26.01%123.89M
-19.50%114.52M
-10.21%89.81M
-21.67%50.44M
Less:Minority Profit
-22.95%8.08M
23.72%5.19M
65.68%37.12M
30.87%14.21M
34.88%10.48M
4.80%4.2M
15.16%22.4M
114.69%10.85M
2,606,814.58%7.77M
36,393,936.18%4M
Net profit of parent company owners
-14.73%79.2M
62.28%41.65M
48.24%150.45M
43.37%148.63M
13.23%92.89M
-44.72%25.67M
-31.42%101.49M
-24.45%103.67M
-17.98%82.04M
-27.89%46.44M
Earning per share
Basic earning per share
-15.25%0.5
68.75%0.27
47.69%0.96
43.37%0.9498
13.46%0.59
-46.67%0.16
-30.85%0.65
-23.88%0.6625
-17.46%0.52
-26.83%0.3
Diluted earning per share
-15.25%0.5
68.75%0.27
47.69%0.96
43.37%0.9498
13.46%0.59
-46.67%0.16
-30.85%0.65
-23.88%0.6625
-17.46%0.52
-26.83%0.3
Other composite income
-80.19%18.88M
-53.15%38.11M
125.51%6.3M
179.41%45.73M
330.76%95.33M
524.86%81.34M
85.60%-24.69M
68.78%-57.58M
72.80%-41.31M
85.53%-19.14M
Other composite income of parent company owners
-80.19%18.88M
-53.15%38.11M
125.51%6.3M
179.41%45.73M
330.76%95.33M
524.86%81.34M
85.60%-24.69M
68.16%-57.58M
72.80%-41.31M
85.53%-19.14M
Total composite income
-46.57%106.16M
-23.60%84.95M
95.43%193.87M
266.26%208.57M
309.68%198.7M
255.34%111.2M
2,567.29%99.2M
235.09%56.94M
193.52%48.5M
146.10%31.3M
Total composite income of parent company owners
-47.89%98.08M
-25.46%79.76M
104.11%156.75M
321.70%194.36M
362.13%188.22M
292.09%107.01M
427.13%76.8M
205.58%46.09M
178.53%40.73M
140.20%27.29M
Total composite income of minority owners
-22.95%8.08M
23.72%5.19M
65.68%37.12M
30.87%14.21M
34.88%10.48M
4.80%4.2M
15.16%22.4M
623.40%10.85M
2,606,814.58%7.77M
36,393,936.18%4M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -10.16%405.02M20.67%199.24M6.15%920.01M22.46%720.04M21.33%450.84M5.71%165.11M7.03%866.73M-1.44%587.99M-18.43%371.59M-25.99%156.19M
Operating revenue -10.16%405.02M20.67%199.24M6.15%920.01M22.46%720.04M21.33%450.84M5.71%165.11M7.03%866.73M-1.44%587.99M-18.43%371.59M-25.99%156.19M
Other operating revenue -73.94%491.76K-----85.60%2.26M-----88.02%1.89M-----86.57%15.68M-----81.65%15.76M----
Total operating cost -8.70%317.15M11.98%150.67M6.36%773.68M8.37%548.85M9.21%347.35M5.51%134.55M8.14%727.45M9.78%506.47M-11.94%318.06M-10.42%127.53M
Operating cost -10.74%42.39M27.67%22.46M-19.90%101.05M-14.33%73.22M-12.44%47.49M-17.26%17.59M19.29%126.16M9.24%85.48M-1.26%54.23M23.15%21.26M
Operating tax surcharges 14.00%3.46M-4.88%1.33M-9.19%5.9M-7.54%4.64M-15.34%3.03M-12.96%1.4M-25.24%6.5M-26.06%5.01M-31.37%3.58M-46.11%1.61M
Operating expense -11.75%193.75M19.72%90.45M11.68%472.59M13.51%344.49M17.42%219.53M5.61%75.55M8.14%423.15M14.95%303.49M-13.59%186.97M-23.34%71.54M
Administration expense 22.07%56.52M26.78%26.16M7.76%110.7M-4.86%70.32M-3.12%46.3M-0.16%20.64M16.66%102.72M15.93%73.91M11.83%47.79M15.12%20.67M
Financial expense 75.66%-2.26M43.70%-1.05M35.84%-11.46M31.54%-11.03M8.53%-9.29M56.33%-1.87M23.65%-17.86M10.01%-16.12M16.55%-10.15M18.22%-4.28M
-Interest expense (Financial expense) 328.56%2.64M314.84%1.23M221.89%2.78M117.45%1.23M55.42%615.48K42.45%297.32K-38.66%864.06K-46.15%565.22K-50.95%396.02K-41.71%208.73K
-Interest Income (Financial expense) 7.47%-6.36M9.92%-2.92M25.63%-13.77M31.38%-10.02M29.82%-6.87M28.90%-3.24M24.65%-18.52M22.75%-14.59M22.72%-9.79M24.83%-4.56M
Research and development -42.18%23.29M-46.72%11.32M9.38%94.91M22.87%67.22M13.01%40.29M26.98%21.24M-15.15%86.78M-17.66%54.71M-34.08%35.65M4.11%16.73M
Credit Impairment Loss -124.61%-180.06K-100.30%-4.22K-232.40%-7.25M-317.39%-2.09M-117.11%-80.17K-31.28%1.39M-578.90%-2.18M161.26%960.72K127.83%468.43K154.59%2.02M
Asset Impairment Loss ---------161.49%-11.91M---------------4.56M------------
Other net revenue -23.90%13.05M-67.86%1.7M-313.40%-3.04M-59.93%17.34M-60.60%17.15M-79.49%5.28M-97.41%1.43M87.07%43.26M141.92%43.54M480.22%25.74M
Fair value change income 153.15%923.48K100.59%1.05M86.81%-866.8K-1,337.16%-1.64M---1.74M-20.09%522.45K-115.76%-6.57M--132.62K-----59.47%653.82K
Invest income -0.53%10.11M-138.89%-536.93K616.30%5.56M-61.86%10.78M-65.16%10.16M-93.57%1.38M82.17%-1.08M326.71%28.27M315.12%29.18M11,104.37%21.49M
-Including: Investment income associates -20.72%-1.22M-91.44%-657.01K7.20%-8.79M-109.38%-1.9M-104.77%-1.01M-101.60%-343.2K-225.96%-9.47M1,502.43%20.22M2,132.89%21.12M11,087.81%21.46M
Asset deal income -----------8.23K----------------------------
Other revenue -75.01%2.2M-40.15%1.19M-27.69%11.43M-26.02%10.28M-36.61%8.81M25.91%1.99M-17.07%15.81M-23.09%13.9M9.82%13.9M-29.07%1.58M
Operating profit -16.33%100.93M40.27%50.26M1.83%143.28M51.09%188.53M24.28%120.64M-34.14%35.83M-26.83%140.7M-21.22%124.78M-13.63%97.07M-25.60%54.41M
Add:Non operating Income -98.29%978.72-99.11%444.93-48.38%261.5K-49.07%257.56K1,201.68%57.38K2,292.92%50.19K-87.64%506.62K9,282.50%505.72K203.60%4.41K188.88%2.1K
Less:Non operating expense -83.91%129.65K-100.00%26.662,229.06%20.81M58.03%1.01M238.14%805.78K1,194.09%802.24K-88.14%893.56K19.52%638.3K1,705.46%238.3K404.73%61.99K
Total profit -15.92%100.8M43.28%50.26M-12.53%122.73M50.64%187.77M23.81%119.89M-35.45%35.08M-25.70%140.32M-21.04%124.65M-13.82%96.83M-25.67%54.35M
Less:Income tax cost -18.12%13.52M-34.48%3.42M-494.83%-64.84M146.32%24.94M135.22%16.52M33.49%5.22M-23.32%16.42M-35.07%10.12M-43.12%7.02M-55.19%3.91M
Net profit -15.57%87.28M56.86%46.85M51.40%187.57M42.19%162.84M15.10%103.37M-40.79%29.86M-26.01%123.89M-19.50%114.52M-10.21%89.81M-21.67%50.44M
Net profit from continuing operation -15.57%87.28M56.86%46.85M51.40%187.57M42.19%162.84M15.10%103.37M-40.79%29.86M-26.01%123.89M-19.50%114.52M-10.21%89.81M-21.67%50.44M
Less:Minority Profit -22.95%8.08M23.72%5.19M65.68%37.12M30.87%14.21M34.88%10.48M4.80%4.2M15.16%22.4M114.69%10.85M2,606,814.58%7.77M36,393,936.18%4M
Net profit of parent company owners -14.73%79.2M62.28%41.65M48.24%150.45M43.37%148.63M13.23%92.89M-44.72%25.67M-31.42%101.49M-24.45%103.67M-17.98%82.04M-27.89%46.44M
Earning per share
Basic earning per share -15.25%0.568.75%0.2747.69%0.9643.37%0.949813.46%0.59-46.67%0.16-30.85%0.65-23.88%0.6625-17.46%0.52-26.83%0.3
Diluted earning per share -15.25%0.568.75%0.2747.69%0.9643.37%0.949813.46%0.59-46.67%0.16-30.85%0.65-23.88%0.6625-17.46%0.52-26.83%0.3
Other composite income -80.19%18.88M-53.15%38.11M125.51%6.3M179.41%45.73M330.76%95.33M524.86%81.34M85.60%-24.69M68.78%-57.58M72.80%-41.31M85.53%-19.14M
Other composite income of parent company owners -80.19%18.88M-53.15%38.11M125.51%6.3M179.41%45.73M330.76%95.33M524.86%81.34M85.60%-24.69M68.16%-57.58M72.80%-41.31M85.53%-19.14M
Total composite income -46.57%106.16M-23.60%84.95M95.43%193.87M266.26%208.57M309.68%198.7M255.34%111.2M2,567.29%99.2M235.09%56.94M193.52%48.5M146.10%31.3M
Total composite income of parent company owners -47.89%98.08M-25.46%79.76M104.11%156.75M321.70%194.36M362.13%188.22M292.09%107.01M427.13%76.8M205.58%46.09M178.53%40.73M140.20%27.29M
Total composite income of minority owners -22.95%8.08M23.72%5.19M65.68%37.12M30.87%14.21M34.88%10.48M4.80%4.2M15.16%22.4M623.40%10.85M2,606,814.58%7.77M36,393,936.18%4M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data